| 667928 |
FRONTIERS IN ONCOLOGY |
Improving the Prediction of Benign or Malignant Breast Masses Using a Combination of Image Biomarkers and Clinical Parameters |
2021-03-22 |
10.3389/fonc.2021.629321 |
Cui Yanhua, Li Yun, Xing Dong, Bai Tong, Dong Jiwen, Zhu Jian |
| 667927 |
FRONTIERS IN ONCOLOGY |
An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma |
2021-03-22 |
10.3389/fonc.2021.644416 |
Lin Zhuo, Xu Qian, Miao Dan, Yu Fujun |
| 667926 |
FRONTIERS IN ONCOLOGY |
Review of MR-Guided Radiotherapy for Esophageal Cancer |
2021-03-22 |
10.3389/fonc.2021.628009 |
Lee Sangjune Laurence, Bassetti Michael, Meijer Gert J., Mook Stella |
| 667925 |
FRONTIERS IN ONCOLOGY |
The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis |
2021-03-22 |
10.3389/fonc.2021.634579 |
Liu Hao, Zhang Zhe, Han Yanan, Fan Ahui, Liu Haiming, Zhang Xiangyuan, Liu Yanhong, Zhang Rugang, Liu Wanning, Lu Yuanyuan, Fan Daiming, Zhao Xiaodi, Nie Yongzhan |
| 667924 |
FRONTIERS IN ONCOLOGY |
Abnormal Elevation of Anti-Mullerian Hormone and Androgen Levels Presenting as Granulosa Cell Tumor |
2021-03-22 |
10.3389/fonc.2021.641166 |
Chi Hongbin, Huang Ning, Liang Huamao, Li Rong, Liu Congrong, Qiao Jie |
| 667923 |
FRONTIERS IN ONCOLOGY |
Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database |
2021-03-22 |
10.3389/fonc.2021.546672 |
Lee Jung Soo, Kim Seoree, Sung Soo-Yoon, Kim Yeo Hyung, Lee Hyun Woo, Hong Ji Hyung, Ko Yoon Ho |
| 667922 |
FRONTIERS IN ONCOLOGY |
The Dual-Role of Methylglyoxal in Tumor Progression – Novel Therapeutic Approaches |
2021-03-22 |
10.3389/fonc.2021.645686 |
Leone Alessia, Nigro Cecilia, Nicolò Antonella, Prevenzano Immacolata, Formisano Pietro, Beguinot Francesco, Miele Claudia |
| 667921 |
FRONTIERS IN ONCOLOGY |
Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients |
2021-03-22 |
10.3389/fonc.2021.646946 |
Zhang Yao, Xiao Chao, Li Jing, Song Lu-xi, Zhao You-shan, Han Shuang, Li Zhao-wei, Guo Cha, Zhao Jun-gong, Chang Chun-kang |
| 667920 |
FRONTIERS IN ONCOLOGY |
Identification of IFN-Induced Transmembrane Protein 1 With Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis |
2021-03-22 |
10.3389/fonc.2021.626883 |
Wu Lingyun, Zhu Xinli, Yan Danfang, Tang Mengmeng, Ma Chiyuan, Yan Senxiang |
| 667919 |
FRONTIERS IN ONCOLOGY |
Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer |
2021-03-22 |
10.3389/fonc.2021.596542 |
Zhou Li, Huang Litang, Xu Qiuli, Lv Yanling, Wang Zimu, Zhan Ping, Han Hedong, Shao Yang, Lin Dang, Lv Tangfeng, Song Yong |
